The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis

J Exp Med. 1999 Mar 15;189(6):957-68. doi: 10.1084/jem.189.6.957.

Abstract

Aberrant activation of cell cycle molecules has been postulated to play a role in apoptosis ("catastrophic cell cycle"). Here we show that in noncycling developing thymocytes, the cyclin- dependent kinase Cdk2 is activated in response to all specific and nonspecific apoptotic stimuli tested, including peptide-specific thymocyte apoptosis. Cdk2 was found to function upstream of the tumor suppressor p53, transactivation of the death promoter Bax, alterations of mitochondrial permeability, Bcl-2, caspase activation, and caspase-dependent proteolytic cleavage of the retinoblastoma protein. Inhibition of Cdk2 completely protected thymocytes from apoptosis, mitochondrial changes, and caspase activation. These data provide the first evidence that Cdk2 activity is crucial for the induction of thymocyte apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis*
  • CDC2-CDC28 Kinases*
  • Caspases / physiology
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinases / physiology*
  • Female
  • Male
  • Membrane Potentials
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Mitochondria / metabolism
  • Protein Serine-Threonine Kinases / physiology*
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / physiology
  • Retinoblastoma Protein / metabolism
  • T-Lymphocytes / physiology*
  • Tumor Suppressor Protein p53 / metabolism
  • bcl-2-Associated X Protein

Substances

  • Bax protein, mouse
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Retinoblastoma Protein
  • Tumor Suppressor Protein p53
  • bcl-2-Associated X Protein
  • Protein Serine-Threonine Kinases
  • CDC2-CDC28 Kinases
  • Cdk2 protein, mouse
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinases
  • Caspases